According to Vitrolife AB's latest financial reports the company's current revenue (TTM ) is A$0.52 Billion. In 2024 the company made a revenue of A$0.54 Billion an increase over the revenue in the year 2023 that were of A$0.48 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | A$0.53 B | -2.89% |
2024 | A$0.54 B | 11.82% |
2023 | A$0.48 B | 5.55% |
2022 | A$0.46 B | 75.57% |
2021 | A$0.26 B | 46.27% |
2020 | A$0.18 B | -19.44% |
2019 | A$0.22 B | 20.59% |
2018 | A$0.18 B | 16.56% |
2017 | A$0.15 B | 15.14% |
2016 | A$0.13 B | 17.51% |
2015 | A$0.11 B | 32.42% |
2014 | A$88.95 M | 14.08% |
2013 | A$77.97 M | 48.79% |
2012 | A$52.4 M | 6.33% |
2011 | A$49.28 M | 18.75% |
2010 | A$41.5 M |